Skip to main content

Table 4 Anticancer Treatment Following Intensive Care Unit Discharge

From: Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013

Variable

Total

Cancer status at admission in ICU (miss. = 3)

Controlled Cancer or in Remission < 5 Years

Patients With Newly Diagnosed Cancer / Recurrence

Patients With Cancer in Progression

At 3 months

n = 166

n = 59, miss. = 11

n = 66, miss. = 8

n = 38, miss. = 10

Anticancer treatment

74 (55)

14 (29)

40 (69)

19 (68)

- Chemotherapy

51 (38)

10 (21)

26 (45)

14 (50)

- Radiotherapy

17 (13)

2 (4)

15 (26)

0

- Surgery

7 (5)

0

6 (10)

1 (4)

- Other

12 (9)

4 (8)

3 (5)

4 (14)

No treatment indication

48 (29)

29 (49)

14 (21)

5 (13)

Palliative care

13 (8)

5 (8)

4 (6)

4 (11)

At 6 months

n = 146

n = 56, miss. = 15

n = 58, miss. = 15

n = 29, miss. = 9

Anticancer treatment

46 (44)

15 (37)

17 (40)

13 (29)

- Chemotherapy

28 (27)

7 (17)

11 (26)

9 (45)

- Radiotherapy

3 (3)

1 (2)

2 (5)

0

- Surgery

4 (4)

1 (2)

2 (5)

1 (5)

- Other

15 (14)

7 (17)

4 (9)

3 (15)

No treatment indication

46 (32)

23 (41)

20 (34)

3 (10)

Palliative care

13 (9)

3 (5)

6 (10)

4 (14)

  1. ICU intensive care unit, miss. missing data
  2. aVariables not mutually exclusive
  3. bTargeted therapy, immunotherapy, hormone therapy